Curriculum Vitae

Upstate Cardiology Division of Research

Crescendo

Randomized, multinational, multicenter, double-blind, placebo-controlled, two-arm parallel group trial of rimonabant 20-mg OD for reducing the risk of major cardiovascular events in abdominally obese patients with clustering risk factors  (Sanofi-Aventis)

Early ACS

Early Glycoprotein IIb/IIIa Inhibition in Non-ST-segment Elevation Acute Coronary Syndrome:  A Randomized, Placebo-Controlled Trial Evaluating the Clinical Benefits of Early Front-loaded Eptifibatide in the Treatment of Patients with Non-ST-segment Elevation Acute Coronary Syndrome   (Millennium/Schering- Plough)

Aware

Analysis of a New AT/AF Detection Algorithm in Patients with Atrial Arrhythmias   (St. Jude)

Stradivarius

Strategy To Reduce Atherosclerosis Development Involving Administration of Rimonabant – The Intravascular Ultrasound Study   (Sanofi-Aventis)

Illustrate

A Phase 3, open-label, multisite, randomized, parallel group study of the efficacy and safety of fixed combination torcetrapib/atorvastatin administered once daily (q.d.) compared to simvastatin for 6 weeks in subjects with hypercholesterolemia  (Pfizer)

Cross

Chronic Total Occlusion Revascularization Registry (LuMend)

TIMI-38

A Comparison of CS-747 and Clopidogrel in Acute Coronary Syndrome Subjects who are to Undergo Percutaneous Coronary Intervention (Eli Lilly)

Athena

A Phase III Placebo-Controlled, Double-Blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in patients with Atrial Fibrillation/Atrial Flutter (AF/AFL).  (Sanofi-Aventis)

P3   

Pacemaker Patient Profiling Study (Medtronic)

Capture

Complete Automatic Pacing Threshold Utilization Recorded by EnPulse (Medtronic)

Adonis

Phase III American-Australian-African Trial with Dronedarone in Atrial Fibrillation or Flutter.  Patients for the Maintenance of Sinus Rhythm   (Sanofi-Aventis)

Discovery

A Phase II, Multi-Center, Double-Blind, Placebo Controlled, Dose-Finding Efficacy and Safety Study of the A-Adenosine Receptor Agonist DTI-0009 Administered Intravenously to Patients with Atrial Fibrillation (Aderis Pharmaceuticals)

Periscope

A Double Blind Randomized Comparator-Controlled Study in Subjects with Type II Diabetes Mellitus Comparing the Effect of Pioglitazone HCl versus Glimepiride on the Rate of Progression of Atherosclerotic Disease as Measured by Intravascular Ultrasound  (Takeda)

Active

Atrial Fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events  (Sanofi-Aventis)

Charisma

Study EFC4505 Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance  (Sanofi-Aventis)

OAT

Occluded Artery Trial  (National Institutes of Health)

SportIFV

Ximelagatran as an Effective and Convenient Replacement for Warfarin for Prevention of Stroke in Atrial Fibrillation  (AstraZeneca)

PRINCE

Pravastatin Inflammation/CRP Evaluation  (Bristol-Myers)

FIRE

Filter Wire During Transluminal Intervention of Saphenous Vein Grafts – Randomized Multi-Center  (Boston Scientific)

Castle

A Randomized Double-Blind, Multi-Center, Parallel-Arm Study to Assess the Long-Term Effects of Pletal (cilostazol) Versus Placebo Administered Dually to Patients with Intermittent Claudication Secondary to Peripheral Artery Disease (Sanofi-Aventis)

Everest

Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Long-Term Efficacy and Safety of Dual Tolvaptan Tablets in Subjects Hospitalized with Worsening Congestive Heart Failure  (Otsuka)

Vision-302

Vasodilator Induced Stress in Concordance with Adenosine.  (King Pharmaceuticals)

XANADU-ACS

A Safety and Efficacy Assessment of DX-9065a in Patients with Non-ST Elevation Acute Coronary Syndrome  (Daichii Pharmaceuticals)

PRIDE

Protection During Saphenous Vein Graft Intervention to Prevent Distal Embolization  (Kensey Nash)

Improve HF

Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting  (Medtronic)

PLATO

A Randomized, Double-blind, Parallel Group, Phase 3, Efficacy and Safety Study of AZD6140 Compared with Clopidogrel for Prevention of Vascular Events in Patients with Non-ST or ST Elevation Acute Coronary Syndromes (ACS)

[PLATO - A Study of PLATelet inhibition and Patient Outcomes.]  (AstraZeneca)

POSEIDON

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral BG9928 in Patients with Heart Failure and Renal Insufficiency  (Biogen Idec)

ATLAS ACS TIMI 46

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Escalation and Dose-Confirmation Study to Evaluate the Safety and Efficacy of Rivaroxaban in Combination with Aspirin Alone or with Aspirin and a Thienopyridine in Subjects with Acute Coronary Syndromes  (Johnson & Johnson)

AMEthyst

The Assessment of the Medtronic AVE Interceptor® Saphenous Vein Graft Filter System   (Medtronic)